BioCentury | Mar 30, 2009
Emerging Company Profile

Carigent: The tail is the tale

...circulation and reach target organs before the delivery device degrades or prematurely releases its payload. Carigent Therapeutics Inc....
...suitable for packaging and delivering several drug classes, including biologics. President Seth Feuerstein told BioCentury Carigent's...
...date has been on delivering RNAi, as that's where the demand has been. Exactly how Carigent's...
BioCentury | Mar 30, 2009
Emerging Company Profile

Corporate Profile

Carigent Therapeutics Inc. New Haven, Conn. Technology: Polymer-based drug delivery Disease focus: Cancer, cardiovascular, autoimmune Clinical status: Preclinical Founded: 2007 by W. Mark Saltzman, Tarek Fahmy and Seth Feuerstein University collaborators: Yale University and Cornell...
BioCentury | Dec 3, 2007
Company News

HistoRx board of directors update

...Conn. Business: Diagnostic Appointed: Gregory Gardiner, a director, as chairman; and Seth Feuerstein, president of Carigent Therapeutics Inc. WIR...
Items per page:
1 - 3 of 3
BioCentury | Mar 30, 2009
Emerging Company Profile

Carigent: The tail is the tale

...circulation and reach target organs before the delivery device degrades or prematurely releases its payload. Carigent Therapeutics Inc....
...suitable for packaging and delivering several drug classes, including biologics. President Seth Feuerstein told BioCentury Carigent's...
...date has been on delivering RNAi, as that's where the demand has been. Exactly how Carigent's...
BioCentury | Mar 30, 2009
Emerging Company Profile

Corporate Profile

Carigent Therapeutics Inc. New Haven, Conn. Technology: Polymer-based drug delivery Disease focus: Cancer, cardiovascular, autoimmune Clinical status: Preclinical Founded: 2007 by W. Mark Saltzman, Tarek Fahmy and Seth Feuerstein University collaborators: Yale University and Cornell...
BioCentury | Dec 3, 2007
Company News

HistoRx board of directors update

...Conn. Business: Diagnostic Appointed: Gregory Gardiner, a director, as chairman; and Seth Feuerstein, president of Carigent Therapeutics Inc. WIR...
Items per page:
1 - 3 of 3